Allogeneic mesenchymal stem cells may be a viable treatment modality in cerebral palsy

Table 1 Patient characteristics

		Frequency	%
Age, yr	1	1	25.0
	4	1	25.0
	9	2	50.0
Sex	Female	1	25.0
	Male	3	75.0
Etiology of cerebral palsy	Hypoxia during birth	2	50.0
	Hypoxia with bleeding in the surgical field after tonsillectomy operation	1	25.0
	Cardiac arrest	1	25.0
Comorbidity	None	4	100.0
Cerebral palsy duration and first transplantation	1 year	1	25.0
	13 months	1	25.0
	7 years	1	25.0
	9 years	1	25.0

Table 2 The change in the pre- and post-transplantation mean scores of the modified Ashworth scale

		n	Mean	SD	Mean rank	χ2	df	P value
Right	Preoperative	4	20.00	6.06	5.50	17.414	5	0.004
	Postoperative 1-wk	4	19.75	6.02	5.13
	Postoperative 1-month	4	19.00	5.48	3.88
	Postoperative 2-month	4	18.25	5.74	2.75
	Postoperative 4-month	4	17.75	5.25	1.88
	Postoperative 1-year	4	17.75	5.25	1.88
Left	Preoperative	4	20.00	6.06	5.38	17.368	5	0.004
	Postoperative 1-wk	4	19.75	6.02	5.00
	Postoperative 1-month	4	19.50	6.35	4.25
	Postoperative 2-month	4	18.25	5.74	2.63
	Postoperative 4-month	4	17.75	5.25	1.88
	Postoperative 1-year	4	17.75	5.25	1.88